Merck (MRK) Other Non-Current Assets (2016 - 2025)
Merck (MRK) has disclosed Other Non-Current Assets for 17 consecutive years, with $18.8 billion as the latest value for Q4 2025.
- On a quarterly basis, Other Non-Current Assets rose 17.29% to $18.8 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.8 billion, a 17.29% increase, with the full-year FY2025 number at $18.8 billion, up 17.29% from a year prior.
- Other Non-Current Assets was $18.8 billion for Q4 2025 at Merck, up from $18.3 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $18.8 billion in Q4 2025 to a low of $81.0 million in Q1 2021.
- A 5-year average of $11.4 billion and a median of $12.3 billion in 2024 define the central range for Other Non-Current Assets.
- Peak YoY movement for Other Non-Current Assets: tumbled 49.2% in 2021, then surged 599.05% in 2022.
- Merck's Other Non-Current Assets stood at $1.4 billion in 2021, then soared by 599.05% to $9.5 billion in 2022, then grew by 25.9% to $12.0 billion in 2023, then soared by 33.74% to $16.0 billion in 2024, then increased by 17.29% to $18.8 billion in 2025.
- Per Business Quant, the three most recent readings for MRK's Other Non-Current Assets are $18.8 billion (Q4 2025), $18.3 billion (Q3 2025), and $16.0 billion (Q4 2024).